Supported by

Left main and multivessel disease

Find all the latest content on left main and multivessel disease published on this website.

The left main coronary artery provides the primary source of blood flow to the left ventricle. Diseases affecting the left main, by itself or in combination with multivessel disease, place the patient at significant risk for life-threatening cardiovascular events. Treatment requires an understanding of all available tools, devices and techniques, like those employed in invasive imaging and functional assessment, as well as taking into account underlying comorbidities such as diabetes. Advances in imaging techniques, as well as the use of adjunctive pharmacotherapy, vascular access or invasive interventions such as bypass surgery, are important, as are understanding bleeding risks. Use the filters below to access PCRonline resources.

Filtered By
Left main and multivessel disease

422 results

CT guidance for coronary interventions - PCR e-Course 2020 Hot lines

26 Jun 2020 – From PCR e-Course 2020

Watch a series of Hot Lines on CT-guidance for PCI presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: CT-FFR CHINA, CAST-FFR, CT-QFR vs. myocardial perfusion imaging, CT-CTO trial, CCTA for optimal fluoroscopic coronary projections.

CT guidance for coronary interventions

PCR e-Course 2020 Late-Breaking Trials - part 2

26 Jun 2020 – From PCR e-Course 2020

Watch a series of Late-Breaking Trials presented during the PCR e-Course 2020 and see how they might have an impact on your practice: 

  • 2-year safety of revascularisation deferral based on iFR or FFR
  • CABG and PCI in patients with CTO and multivessel disease
  • Routine revascularisation vs. medical therapy
PCR e-Course 2020 Late-Breaking Trials

Non-culprit stenosis revascularisation in STEMI patients with multivessel disease: which, when and how?

26 Jun 2020 – From PCR e-Course 2020

Watch this case discussion if you want to understand how to invasively evaluate non-culprit stenosis in STEMI, to discuss optimal timing of non-culprit PCI and to understand how to implement novel evidence and guideline recommendations to your local practice.

This session was originally presented during PCR e-Course...

Non-culprit stenosis revasc. in STEMI patients with MVD: which, when and how?

PCR e-Course 2020 Clinical cases

25 Jun 2020 – From PCR e-Course 2020

Watch a series of best clinical cases presented at the PCR e-Course 2020:

  • ACS-patient with culprit in a coronary ectasia
  • Coronary stenting in an ectatic artery
  • Challenging PCI after aortic valve-in-valve implantation
  • Cisplatin-induced coronary artery thrombosis presented as ACS
  • MOCA I study: microvascular obstruction measured using dMVR
  • The many faces of in-stent...
PCR e-Course Clinical cases

Hotlines and innovations on left main & multivessel disease - PCR e-Course 2020

25 Jun 2020 – From PCR e-Course 2020

View a selection of hot lines from PCR e-Course 2020 on the topic of left main & multivessel disease:

  • One-year clinical outcomes of complex PCI treated with use of Ultimaster stent
  • Impact of residual SYNTAX score on all-cause death at 10 yrs in the SYNTAX trial
Hotlines and innovations on left main & multivessel disease

SYNERGY MEGATRON - Transforming your left main bifurcation strategy for improved outcomes

Watch this session if you want to review steps for PCI in complex left main bifurcation lesions, to advance your knowledge on IVUS-guided PCI in left main disease and to learn about a purpose-built new stent platform for large vessels and left main.

SYNERGY MEGATRON - Transforming your left main bifurcation strategy for improved outcomes

The unique challenges of left main PCI

Watch this session if you want to understand why the left main PCI approach and techniques are unique to the anatomy, to understand the EBC consensus and other evidence on left main PCI and to review a left main PCI real world case.

Speakers: Goran Stankovic, Francesco...

The unique challenges of left main PCI

Are higher operator volumes for unprotected left main stem percutaneous coronary intervention associated with improved patient outcomes?

15 Jun 2020

The presented results appear to further strengthen the notion that operator’s experience may be an important effect modifier in LM PCI.

Dejan Milasinovic

Reviewer

Dejan Milasinovic
Are higher operator volumes for unprotected LM stem PCI associated with improved patient outcomes?

Multi- vs culprit-vessel percutaneous coronary intervention in cardiogenic shock

04 May 2020

This study compares outcomes of patients enrolled in the National Cardiogenic Shock Initiative (NCSI) registry treated using a strategy of MV-PCI vs CV-PCI and examines outcomes in patients treated with early MCS.

Dr. Mirvat Alasnag

Reviewer

Mirvat Alasnag
Multi- vs culprit-vessel PCI in cardiogenic shock

PCR on Call : a patient with ACS and multivessel disease: the human factor

28 Apr 2020

View the discussion of this case between Salvatore Brugaletta, Kalaivani Mahadevan and Thomas Johnson.

PCR on Call -  A COVID(+) patient with ACS and MVD: the human factor